IP Library Granted Patent US 12,264,351
Granted Patent B2
US 12,264,351 · App. 16/637,188 · Granted Apr 1, 2025

Patent

Inventors: Gale Wichmann (Emeryville, CA); Aditi Khankhoje (Emeryville, CA); Tina Mahatdejkul-Meadows (Emeryville, CA)
Assignee: AMYRIS, INC.
C12P19/56C12N15/81C12P7/40C12N1/185C12R2001/865
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,264,351
App. No.
16/637,188
Granted
Apr 1, 2025
Kind
B2
Abstract

Provided herein are compositions and methods for improved production of steviol glycosides in a host cell. In some embodiments, the host cell is genetically modified to comprise a heterologous nucleotide sequence encoding a Pisum sativum kaurene oxidase or its variant kaurene oxidase. In some embodiments, the host cell further comprises one or more heterologous nucleotide sequence encoding further enzymes of a pathway capable of producing steviol glycosides in the host cell. The compositions and methods described herein provide an efficient route for the heterologous production of steviol glycosides, including but not limited to, rebaudioside D and rebaudioside M.

Claims (22)

1. A genetically modified Saccharomyces cerevisiae host cell that produces one or more steviol glycosides comprising a heterologous nucleic acid encoding a kaurene oxidase comprising an amino acid sequence having at least 80% sequence identity to SEQ ID NO: 1, wherein the genetically modified host cell is capable of converting kaurene to kaurenoic acid at an efficiency of greater than 30%, and wherein the genetically modified host cell produces one or more steviol glycosides,

wherein the genetically modified Saccharomyces cerevisiae host cell further comprises one or more heterologous nucleic acids, wherein the one or more heterologous nucleic acids encode enzymes comprising a geranylgeranylpyrophosphate synthase, a copalyl diphosphate synthase, an ent-kaurene synthase, a polypeptide having steviol synthase activity, and one or more polypeptides having UDP glycosyltransferase activity.

2. The genetically modified Saccharomyces cerevisiae host cell of claim 1 , wherein the kaurene oxidase comprises the sequence of SEQ ID NO:1.

3. The genetically modified Saccharomyces cerevisiae host cell of claim 1 , wherein the kaurene oxidase is capable of oxidation of the C19 position of kaurene, kaurenol, and/or kaurenal.

4. The genetically modified Saccharomyces cerevisiae host cell of claim 1 , wherein the kaurene oxidase is encoded by a heterologous nucleic acid, wherein the heterologous nucleic acid comprises a nucleotide sequence having at least 80% sequence identity to SEQ ID NO:15.

5. The genetically modified Saccharomyces cerevisiae host cell of claim 1 , wherein the kaurene oxidase is encoded by a heterologous nucleic acid having the sequence of SEQ ID NO:15.

6. The genetically modified Saccharomyces cerevisiae host cell of claim 1 , wherein the kaurene oxidase comprises an amino acid sequence having at least 95% sequence identity to SEQ ID NO:1.

7. The genetically modified Saccharomyces cerevisiae host cell of claim 1 that is capable of converting kaurene to kaurenoic acid at an efficiency of greater than 55%.

8. The genetically modified Saccharomyces cerevisiae host cell of claim 1 produces kaurenoic acid, steviol, RebD, and/or RebM.

9. The genetically modified Saccharomyces cerevisiae host cell of claim 1 , wherein the one or more heterologous nucleic acids further encode a cytochrome P450 reductase, and wherein the polypeptide having steviol synthase activity is a kaurenoic acid hydroxylase.

10. A method for producing RebD comprising:

(a) culturing a population of the genetically modified host cells of claim 1 in a medium with a carbon source under conditions suitable for making RebD; and

(b) recovering said RebD from the medium.

11. A method for producing RebM comprising:

(a) culturing a population of the genetically modified host cells of claim 1 in a medium with a carbon source under conditions suitable for making RebM; and

(b) recovering said RebM from the medium.

12. A fermentation composition comprising:

(a) a genetically modified host cell comprising

a heterologous nucleic acid encoding a kaurene oxidase having at least 80% sequence identity to SEQ ID NO:1 and capable of converting kaurene to kaurenoic acid at an efficiency of greater than 30%, wherein the genetically modified host cell further comprises one or more heterologous nucleic acids, wherein the one or more heterologous nucleic acids encode enzymes comprising a geranylgeranylpyrophosphate synthase, a copalyl diphosphate synthase, an ent-kaurene synthase, a polypeptide having steviol synthase activity, and one or more polypeptides having UDP glycosyltransferase activity; and

(b) steviol glycosides produced from the genetically modified host cell.

13. The fermentation composition of claim 12 , wherein the steviol glycosides comprise RebA, RebD and RebM at a ratio of RebA:RebD:RebM of at least 1:7:50.

14. A method for producing a steviol glycoside comprising culturing a population of the genetically modified host cells of claim 1 in a medium with a carbon source under conditions suitable for making a steviol glycoside.

Assignments (8)
SECURITY INTEREST Recorded Jul 6, 2025
From: AMYRIS, INC.
To: EUAGORE, LLC
Reel/Frame 071612/0421 →
SECURITY INTEREST Recorded May 24, 2024
From: AMYRIS, INC.
To: EUAGORE, LLC
Reel/Frame 067528/0467 →
SECURITY INTEREST Recorded Aug 17, 2023
From: AMYRIS, INC.; AMYRIS CLEAN BEAUTY, INC.; AMYRIS FUELS, LLC; AB TECHNOLOGIES LLC; APRINNOVA, LLC; AMYRIS-OLINKA, LLC; ONDA BEAUTY INC.; UPLAND 1 LLC; AMYRIS ECO-FAB LLC; CLEAN BEAUTY 4U HOLDINGS, LLC; AMYRIS CLEAN BEAUTY LATAM LTDA; INTERFACES INDUSTRIA E COMERCIA DE COSMETICOS LTDA; AMYRIS BIOTECHNOLOGIA DO BRASIL LTDA; AMYRIS EUROPE TRADING B.V. (NETHERLANDS); AMYRIS BIO PRODCUTS PORTUGAL, UNIPESSOAL, LDA; BEAUTY LABS INTERNATIONAL LIMITED; AMYRIS UK TRADING LIMITED
To: EUAGORE, LLC
Reel/Frame 064619/0778 →
SECURITY INTEREST Recorded Aug 3, 2023
From: AMYRIS CLEAN BEAUTY, INC.; AMYRIS FUELS, LLC; AB TECHNOLOGIES LLC; AMYRIS, INC.
To: MUIRISC, LLC
Reel/Frame 064492/0518 →
RELEASE OF SECURITY INTEREST Recorded Feb 14, 2023
From: NAXYRIS S.A.
To: AMYRIS, INC.
Reel/Frame 062760/0753 →
SECURITY INTEREST Recorded Oct 18, 2022
From: AMYRIS, INC.
To: FORIS VENTURES, LLC
Reel/Frame 061703/0499 →
SECURITY INTEREST Recorded Apr 28, 2020
From: AMYRIS, INC., AS PARENT
To: NAXYRIS S.A., AS LENDER
Reel/Frame 052518/0474 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2020
From: WICHMANN, GALE; KHANKHOJE, ADITI; MAHATDEJKUL-MEADOWS, TINA
To: AMYRIS, INC.
Reel/Frame 051753/0746 →